NiKem Research Receives Approval as a “Crédit d’Impôt Recherche” Certified Company from the French Ministry of Research
News Sep 15, 2008
NiKem Research Srl, an international service provider in the field of Drug Discovery based in Italy, had announced that the French Ministry of Research (FMR) has accepted the company’s request to be included in the list of FMR approved contract research organizations (CROs) carrying out R&D activities for French private companies.
This approval, which is valid for the three year period between 2008 and 2010 and could be renewed afterwards, entitles and will entitle any French private company to claim significant tax credit (“Crédit d’Impôt Recherche”, C.I.R.) for R&D activities executed by NiKem Research on their behalf in the above mentioned time period.
NiKem believes that its C.I.R. certification may now allow a further expansion of business relationships with French companies, and is committed to provide an extremely cost-effective support to any interested French partner.
Giuseppe Giardina, CEO & Managing Director of NiKem, said: "The approval as a C.I.R. certified company by the French Ministry of Research is an important step forward for NiKem. We believe that our already significant business volume with French pharmaceutical and, most importantly, biotech companies will grow: in fact, our high quality standards are now combined with competitive prices and tax credit options. Thus, we expect to at least double our revenues in France in the next three years."
The sweet flavors’ appeal to teens is a major concern for Food and Drug Administration officials, who recently declared teen vaping an epidemic. New research shows flavorings are transforming more than marketing. The chemical additives react to e-liquid, or e-juice, creating new compounds that could trigger irritation and inflammation when inhaled.READ MORE
A new study by investigators from Brigham and Women’s Hospital examined whether pregnancy-related changes may influence how effectively five common AEDs prevent seizures and found that antiepileptic drug clearance significantly changes by the first trimester for the most commonly used medication and by the second trimester for two others.READ MORE
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019
2nd International Conference on Biological & Pharmaceutical Sciences
Jul 12 - Jul 13, 2019
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019